Illumina Inc ILMN

NASDAQ US Life Sciences Tools & Services

$270.00 ▼ -1.42% ($-3.90)

Index member: S&P 500

Open $272.16

Prev Close $273.90

Day Range $267.66 – $276.97

52W Range $88.00 – $277.95

Market Cap $36.18B

P/E (TTM) 49.99

Beta 1.46

EPS (TTM) $5.38

📋 Company Profile

Industry	Life Sciences Tools & Services
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2000-06-28
Shares Out.	151,300,000
Website	illumina.com ↗
Phone	13026587581
Employees	8,650
Revenue	$1.16B
Gross Profit	$770.0M
Net Income	$207.0M
Free Cash Flow	$931.0M
Total Assets	$6.65B
Total Liabilities	$3.81B
Equity	$2.84B

About Illumina Inc

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Illumina Inc is a publicly traded company under the ticker symbol ILMN on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.